The field of AIDS vaccine development is in flux. Important new findings we
re reported in 1993 that led to a rethinking of AIDS vaccine strategies. We
hale been given the challenging task of providing an overview. Rather than
attempting to provide a comprehensive summary, we will restrict our discus
sion to a few major topics, and we ask for understanding if we can only hig
hlight.